Article

Non-neutralizing antibody responses to vesicular stomatitis virus-vectored influenza A virus vaccines correlate with protection

2022-11-03

Abstract excerpt

Seasonal influenza virus infections remain a major global public health burden. In addition, influenza A virus (IAV) exhibits high pandemic potential through zoonotic spread from avian hosts to humans. Currently licensed IAV vaccines are mainly directed against the immuno-dominant surface protein hemagglutinin (HA). Since HA is antigenically highly variable, IAV can escape vaccine-derived immunity through antigeni...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ade61df5-bc39-506e-900e-e746d756942a
DOI: 10.1101/2022.11.02.514911

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Non-neutralizing antibody responses to vesicular stomatitis virus-vectored influenza A virus vaccines correlate with protectionDOI 10.1101/2022.11.02.514911Read

Influenza Virus-Derived CD8 T Cell Epitopes: Implications for the Development of Universal Influenza VaccinesSemantic proximity Read

Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentSemantic proximity Read

Fc-dependent protective efficacy of non-inhibitory antibodies targeting influenza A virus neuraminidase is limited by epitope availabilitySemantic proximity Read

Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A VirusesSemantic proximity Read

Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary useSemantic proximity Read

Virus-like particles as universal influenza vaccinesSemantic proximity Read

Multi-Epitope Peptide-Based and Vaccinia-Based Universal Influenza Vaccine Candidates Subjected to Clinical TrialsSemantic proximity Read

A Universal, Single-Component Multilayered Self-Assembling Protein Nanoparticle Vaccine Based on Extracellular Domains of Matrix Protein 2 Against Both Influenza A and BSemantic proximity Read

T-Cell Immunity to Influenza A VirusesSemantic proximity Read

A VLP Vaccine Induces Broad-Spectrum Cross-Protective Antibody Immunity against H5N1 and H1N1 Subtypes of Influenza A VirusSemantic proximity Read

Strategies to induce broadly protective antibody responses to viral glycoproteinsSemantic proximity Read

Highly conserved influenza A sequences as T cell epitopes-based vaccine targets to address the viral variability.Semantic proximity Read